Clearside Biomedical, Inc. (CLSD)

NASDAQ: CLSD · IEX Real-Time Price · USD

1.230

-0.010 (-0.81%)

At close: Jul 2, 2024, 4:00 PM

1.305

+0.075 (6.10%)

After-hours: Jul 2, 2024, 7:57 PM EDT

Clearside Biomedical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2014
Net Income	-32.49	-32.95	0.38	-18.21	-30.77	Upgrade
Depreciation & Amortization	0.07	0.15	0.18	0.18	0.21	Upgrade
Share-Based Compensation	4.2	4.88	5.05	3.6	4.61	Upgrade
Other Operating Activities	10.08	14.55	-16.34	1.31	-1.12	Upgrade
Operating Cash Flow	-18.14	-13.37	-10.73	-13.12	-27.07	Upgrade
Capital Expenditures	-1.78	-0.25	0	-0.06	-0.03	Upgrade
Change in Investments	0	0	0	0	32.95	Upgrade
Investing Cash Flow	-1.78	-0.25	0	-0.06	32.93	Upgrade
Share Issuance / Repurchase	1.76	0.7	23.78	12.22	13.7	Upgrade
Debt Issued / Paid	-1.35	30.64	0	-4.35	-5	Upgrade
Financing Cash Flow	0.41	31.33	23.78	7.87	8.7	Upgrade
Net Cash Flow	-19.5	17.72	13.05	-5.31	14.55	Upgrade
Free Cash Flow	-19.91	-13.61	-10.73	-13.18	-27.09	Upgrade
Free Cash Flow Margin	-242.06%	-1025.70%	-36.29%	-166.90%	-1246.80%	Upgrade
Free Cash Flow Per Share	-0.32	-0.23	-0.18	-0.28	-0.71	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).